<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="198284">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00509392</url>
  </required_header>
  <id_info>
    <org_study_id>CVL-06-03</org_study_id>
    <nct_id>NCT00509392</nct_id>
  </id_info>
  <brief_title>ClosureFAST vs. Laser Ablation for the Treatment of GSV Disease: A Multicenter, Single-Blinded, Randomized Study.</brief_title>
  <acronym>RECOVERY</acronym>
  <official_title>Radiofrequency Endovenous ClosureFAST vs. Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VNUS Medical Technologies, A Covidien Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VNUS Medical Technologies, A Covidien Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this post-market study is to compare the post-procedure recovery between
      two types of minimally invasive catheter treatments for venous disease in the Great
      Saphenous Vein.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of the post-procedure recovery of radiofrequency treatment vs. laser treatment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">January 2008</completion_date>
  <primary_completion_date type="Actual">January 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-procedure recovery for each treatment group; including post-procedure pain and return to normal activities.</measure>
    <time_frame>30 days following treatment.</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">87</enrollment>
  <condition>Great Saphenous Vein Disease</condition>
  <condition>Venous Reflux</condition>
  <arm_group>
    <arm_group_label>1. RF Ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment of venous disease with a Radiofrequency catheter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2. Endovenous Laser</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment of venous disease with an Endovenous Laser catheter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Segmental RF ablation with the ClosureFAST catheter</intervention_name>
    <description>radiofrequency catheter</description>
    <arm_group_label>1. RF Ablation</arm_group_label>
    <other_name>VNUS</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovenous Laser</intervention_name>
    <description>laser catheter</description>
    <arm_group_label>2. Endovenous Laser</arm_group_label>
    <other_name>Commercially approved laser catheter systems.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All subjects must provide written informed consent.

          -  Must be a candidate for either treatment with RFA or endovenous laser.

        Exclusion Criteria:

          -  Subjects who require additional treatments in either leg within 30 days before or
             after the study procedure.

          -  Subjects who are participating in another investigational study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lian Cunningham, MD</last_name>
    <role>Study Director</role>
    <affiliation>VNUS Medical Technologies, A Covidien Company</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Oregon Health Sciences</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Almeida JI, Kaufman J, GÃ¶ckeritz O, Chopra P, Evans MT, Hoheim DF, Makhoul RG, Richards T, Wenzel C, Raines JK. Radiofrequency endovenous ClosureFAST versus laser ablation for the treatment of great saphenous reflux: a multicenter, single-blinded, randomized study (RECOVERY study). J Vasc Interv Radiol. 2009 Jun;20(6):752-9. doi: 10.1016/j.jvir.2009.03.008. Epub 2009 Apr 22.</citation>
    <PMID>19395275</PMID>
  </results_reference>
  <verification_date>December 2009</verification_date>
  <lastchanged_date>December 11, 2009</lastchanged_date>
  <firstreceived_date>July 27, 2007</firstreceived_date>
  <responsible_party>
    <name_title>VNUS Medical Technologies, Inc</name_title>
    <organization>VNUS Medical Technologies, Inc.</organization>
  </responsible_party>
  <keyword>Varicose veins, venous reflux, GSV disease</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
